Why the study?
Does aggressive treatment based on ANP and LAD monitoring improve cardiac structure and function in peritoneal dialysis patients?
Population
32 peritoneal dialysis (PD) patients in Juntendo University Hospital, Tokyo
Design
Cohort
Follow-up
24 months
Key result
Aggressive treatment based on plasma ANP and LAD in peritoneal dialysis patients significantly reduced left atrial diameter from 36 mm to 33 mm over 24 months (p<0.05).
Authors
Loading...
May support ANP/LAD-guided volume management in PD; leaves open need for RCTs on outcomes.
Cohort (n=32)
No
Does aggressive treatment based on ANP and LAD monitoring improve cardiac structure and function in peritoneal dialysis patients?
p-value: p=<0.05
Aggressive volume and blood pressure management guided by ANP and echocardiography preserves left ventricular structure and function in peritoneal dialysis patients over 24 months.
Io et al. (2010) conducted a cohort in Peritoneal dialysis (n=32). Aggressive treatment based on plasma ANP and LAD was evaluated on Left atrial diameter (LAD) (p=<0.05). Aggressive treatment based on plasma ANP and LAD in peritoneal dialysis patients significantly reduced left atrial diameter from 36 mm to 33 mm over 24 months (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: